However, in a study including more than 630 myeloma patients, bone marrow plasma cell SOST mRNA expression was not different compared with healthy controls, nor was it detected in 56 human or murine myeloma cells lines,100 suggesting that the elevated serum Sclerostin was driven by another source. This evidence concerns the gene SOST and plasma cell myeloma.